Abstract Microbial transglutaminase (MTG) has been used extensively in academic research and the food industries through its cross-linking or posttranslational modification of proteins. Two enzyme engineering approaches were applied to improve MTG activity. One is a novel method of rational mutagenesis, called wateraccessible surface hot-space region-oriented mutagenesis (WASH-ROM). One hundred and fifty-one point mutations were selected at 40 residues, bearing high solventaccessibility surface area, within a 15Å space from the active site Cys64. Among them, 32 mutants showed higher specific activity than the wild type. The other is a random mutagenesis of the whole region of the MTG gene, coupled with a new plate assay screening system, using Corynebacterium Expression System CORYNEX®. This in vivo system allowed us to readily distinguish the change in enzymatic activity by monitoring the intensity of enzymatic reaction-derived color zones surrounding recombinant cells. From the library of 24,000 mutants, ten were finally selected as beneficial mutants exhibiting higher specific activity than the wild type. Furthermore, we found that Ser199Ala mutant with additional N-terminal tetrapeptide showed the highest specific activity (1.7 times higher than the wild type). These various beneficial positions leading to increased specific activity of MTG were identified to achieve further enzyme improvements.
Introduction
Transglutaminases (TGases: protein-glutamine γ-glutamyltransferase, EC 2.3.2.13) are a family of enzymes that catalyze an acyl transfer reaction between a γ-carboxyamide group of a glutamine residue in a peptide chain and an ε-amino group of lysine residue, resulting in the formation of an ε-(γ-glutamyl) lysine cross-linkage. TGases are widely distributed in various cells and tissues of mammals, and their physiological properties have been extensively studied (Beninati et al. 2009 ). The TGases derived from animals are calcium ion-dependent enzymes, and are distributed in most organs, skin, and blood. To date, for example, guinea pig liver TGase (Ikura et al. 1988) , human epidermis keratinocyte TGase (Thacher 1989) , human blood coagulation factor XIII (Ichinose et al. 1986 ) and red sea bream TGase (Yasueda et al. 1995) have been reported. However, the industrially most valuable TGase was found in the genus Streptomyces (Actinomycetes). Streptomyces mobaraensis s-8112 TGase (MTG; microbial transglutaminase) is calcium ion-independent, and basic and applied functional studies have demonstrated its industrial utility (Kuraishi et al. 1996; Motoki and Seguro 1998; Sakamoto et al. 1993; Yokoyama et al. 2004 ). The enzymatic properties of MTG have been characterized Nonaka et al. 1989) . Purified MTG has been analyzed, and its complete amino-acid sequence identified (Kawajiri et al. 1993) . MTG is known to be expressed as a preproenzyme which is processed to the mature form (Pasternack et al. 1998; Umezawa et al. 2004; Zotzel et al. 2003a, b) . Its pro-region is thought to be essential for efficient protein folding, secretion , and suppression of its enzymatic activity (Pasternack et al. 1998) .
MTG has been used in the food industry for the modification of proteins. It is used in the binding of meat or fish and gelled food products such as jelly, yogurt, or cheese. Moreover, it is an enzyme having a large potential utility in manufacturing the materials used in cosmetics, thermostable microcapsules the carriers for immobilized enzymes. To date, the enzyme is produced by conventional fermentation and thus, it would be valuable to develop an efficient system for production of MTG, and various studies of this sort have been reported (Washizu et al. 1994; Yokoyama et al. 2000 Yokoyama et al. , 2002 . Recently, pro-MTG has been efficiently secreted by Corynebacterium glutamicum (Corynebacterium Expression System CORYNEX®; Ajinomoto Co., Inc.), and subsequently activated by the co-expressed protease Kikuchi et al. 2003 ). This strain is used for the industrial production of amino acids such as glutamate, lysine, and others, which have been used in food, animal feed, and pharmaceuticals for several decades. It is nonpathogenic and produces no hazardous toxins. Furthermore, considerable experience has been accumulated concerning the appropriate fermentation conditions. In these respects, it is likely that C. glutamicum is suitable for industrial-scale protein production.
Novel potential applications have emerged in non-food areas. These applications cover a range of areas, including medical engineering, material science, textiles, and leather processing (Fontana et al. 2008; Zhu and Tramper 2008) . There are many promising applications beyond the food area, but it is necessary to improve MTG to fit such applications. For this purpose, C. K. Marx developed a screening method, including a proteolytic activation step of the expressed soluble pro-enzyme, and selected improved thermostability variants by random mutagenesis (Marx et al. 2008) .
For the first challenge to improve the specific activity of MTG, we carried out two engineering approaches, rational mutagenesis targeting the immediately surrounding area of the active center site, Cys64, and random mutagenesis targeting the entire MTG region. The former approach is based on a novel rational mutagenesis method, called water-accessible surface hot-space region-oriented mutagenesis (WASH-ROM). Also, a bacterial enzyme secretionbased plate assay system was developed to efficiently select positive candidates through the screening process. Most of the beneficial mutations with higher specific activities than the wild-type enzyme were different between the two approaches, and the activity increase-related positions and regions were identified in the three-dimensional structure of MTG. Thus, by a combination of different mutagenesis approaches, we found that there are multiple pathways to access beneficial mutations for the acquisition of higher specific activity.
Materials and methods
Bacterial strains, plasmids, and culture medium Escherichia coli JM109, E. coli DH5α and C. glutamicum ATTC13869 were used in this study. E. coli JM109, and E. coli DH5α were purchased from Takara Shuzo (Kyoto, Japan). pPSPTG1 and pPSPTG11 are pro-MTG expression vector Date et al. 2003) . pVSS1 is the SAM-P45 expression vector . The sequence of MTG gene and SAM-P45 gene were exhibited at GenBank: CAA77128.1 and GenBank: D83672.1, respectively.
E. coli JM109 and E. coli DH5α were grown in lysogeny broth, containing kanamycin (Km; 25 μg/ml). E. coli JM109 used as an intermediate host for various plasmid constructions. E. coli DH5α were used as a host for a random mutagenesis library. C. glutamicum was grown in CM2G medium (5 g of glucose, 10 g of tryptone, 10 g of yeast extract, 5 g of NaCl, 0.2 g of DL-methionine per liter of distilled water, adjusted to pH7.2) at 30°C. A MTG-production medium for C. glutamicum was used with MMTG medium (60 g of glucose, 1 g of MgSO 4 , 30 g of (NH 4 ) 2 SO 4 , 1.5 g of KH 2 PO 4 , 0.01 g of FeSO 4 ·7H 2 O, 0.01 g of MnSO 4 ·4H 2 O, 450 μg of thiamine hydrochloride, 450 μg of biotin, 0.15 g of DL-methionine, 50 g of CaCO 3 per liter of distilled water, adjusted to pH7.5) at 30°C. C. glutamicum was transformed by electroporation as described previously (Liebl et al. 1989) . Km (25 μg/ml) or chloramphenicol (Cm; 5 μg/ml) was added to culture media when required.
DNA manipulations
All DNA manipulations followed standard procedures (Sambrook et al. 1989) . PCR with Pyrobest DNA polymerase (Takara Shuzo, Kyoto, Japan) was performed in 50 μl reaction mixtures for 5 min at 94°C, and for 25 cycles of 10 s at 98°C, and 30 s at 55°C, and 3 min at 72°C. Nucleotide sequences were determined by using the BigDye terminator cycle sequencing FS ready reaction kit (Applied Biosystems) and DNA sequencer (model 377; Applied Biosystems).
Activation of pro-MTG
MTG is secreted as a pro-enzyme which is activated by the endoprotease TAMEP (Zotzel et al. 2003a ). TAMEPactivated MTG exhibited an additional N-terminal tetrapeptide Phe-Arg-Ala-Pro (FRAP). FRAP-MTG is processed by a prolyl aminopeptidase SM-TAP (Zotzel et al. 2003b ). Wild-type pro-MTG was secreted by C. glutamicum, carrying pPSPTG1, and subsequently activated by the coexpressed subtilisin-like protease SAM-P45 . SAM-P45-activated MTG also exhibited FRAP-MTG. C. glutamicum, carrying pPSPTG11, secreted pro-MTG, whose C-terminal of pro-peptide was altered from Arg-Ala-Pro to Gly-Pro-Lys. Altered pro-MTG, activated by SAM-P45, exhibited the mature N terminus of the wildtype protein . In case of rational mutagenesis, pro-MTG was secreted by C. glutamicum, carrying pPSPTG11, and subsequently activated by a protease from Bacillus licheniformis (P4860, SigmaAldrich Japan). The activated MTG exhibited the mature N terminus of the wild-type protein. In case of random mutagenesis, wild-type pro-MTG was secreted by C. glutamicum, carrying pPSPTG1, and subsequently activated by the co-expressed subtilisin-like protease SAM-P45. The activated MTG exhibited N-terminal four amino-acid residues extension of the wild-type protein. N-terminal amino-acid sequences were determined using a gas phase protein sequencer (model PSQ; Shimadzu, Kyoto, Japan) equipped with an in-line amino-acid analyzer (model RF-550; Shimadzu).
Rational mutagenesis of MTG
Mutagenesis of the MTG gene was carried out, using QuickChange® II Site-Directed Mutagenesis Kit (STRA-TAGENE®) according to the manufacturer's manual. pro-MTG expression vector pPSPTG11 ) was used for template DNA. Mutagenesis primers were designed, according to the instruction of the mutagenesis kit, in reference to the codons of C. glutamicum. After digestion with DpnI, the resulting plasmids containing the mutated MTG gene were transformed into E. coli JM109. Mutations were confirmed by DNA sequencing, using an ABI DNA sequencer, according to the manufacturer's manual. The mutated plasmids were transformed into C. glutamicum for rational screening.
Construction of a random mutation library based on error-prone PCR For random mutagenesis, 10 ng template DNA (pPSPTG1) were applied in the error-prone PCR reaction (10 mM TrisHCl, 50 mM KCl, 0.1 mg/ml BSA, 5 mM MgCl 2 , 0.25 mM dNTPmix, forward primer (25 pmol/ml), reverse primer (25 pmol/ml), 10% DMSO and 0.5% rTaq polymerase (Takara Shuzo, Kyoto, Japan) ) (Taguchi et al. 1998 ). PCR was performed in 100-μl reaction mixtures for 3 min at 94°C, and for 25 cycles of 2 min at 94°C, and 30 s at 58°C, and 3 min at 72°C. The PCR primers were derived from sequences at the beginning and at the end of the MTG gene without the pro-sequence (forward primer: 5′-GCCCCCGACTCCGACGACAG-3′, reverse primer: 5′-TCGCTGCAGGTCGACTCTAG-3′). The PCR fragment and pPSPTG1 were successively digested by BamHI and BstEII. The digested PCR fragment and a large fragment of pPSPTG1 were ligated and transformed into E. coli DH5α. The E. coli library was transferred to C. glutamicum library below. The E. coli library was divided into 100 E. coli mutants. Plasmids were extracted from mixed 100 E. coli mutants and transformed into C. glutamicum ATTC13869, which carried the SAM-P45 expression vector pVSS1 . 300 C. glutamicum mutants were obtained from each extracted plasmids. A total of 24,000 C. glutamicum mutants were obtained from 8,000 E. coli mutants for random screening.
Cultivation of the recombinant bacteria expressing rational mutants
Deepwell microtiter plates (Flat-Bottom Block, QIAGEN K. K.) were filled with 1 ml CM2G medium, containing 25 mg/ l Km, per well. Each well was inoculated with a single colony of transformed C. glutamicum cells using a sterile toothpick and sealed with a gas permeable adhesive seal (AirPore™ Tape Sheets, QIAGEN K.K.). They were incubated in a shaking incubator (BioShaker M BR-022 TAITEC) at 1,500 rpm, 30°C for 16-20 h. For MTG expression, 50 μl of the culture were used to inoculate a new deepwell microtiter plate containing 1 ml of MMTG medium, containing 25 mg/l Km. It was sealed as described above and incubated in the same shaking incubator at 1,500 rpm and 30°C for 48 h, followed by centrifugation (3,000 rpm, 20 min). A 200 μl of the supernatant were inoculated onto a new deepwell microtiter plate, containing 800 μl of 50 mM sodium phosphate buffer, pH7 and 0.0125% Protease from Bacillus licheniformis (P4860, Sigma-Aldrich Japan). It was incubated at 30°C for 16 h for activation of MTG. After proteolytic activation, wild-type MTG was stable. In the case of test tube culture, a single colony of transformed C. glutamicum cells was inoculated with 3 ml CM2G medium, containing 25 mg/l Km. It was incubated in a shaking incubator (BR-3000LF TAITEC) at 120 rpm, 30°C for 16-20 h. For MTG expression, 200 μl of the culture were used to inoculate a new test tube containing 4 ml of MMTG medium, containing 25 mg/l Km. It was incubated in the same shaking incubator at 120 rpm and 30°C for 48 h, followed by centrifugation (10,000 rpm, 10 min.). Proteolytic activation was carried out in a new test tube, as described above.
Assay of MTG activity MTG activity was measured by the colorimetric hydroxamate procedure using N-carbobenzoxy-L-glutaminylglycine (Z-Gln-Gly) . Solution A consisted of 0.03 M Z-Gln-Gly, 0.1 M NH 2 OH, 0.01 M glutathione (reduced form) and 50 mM MES, pH6.0. Solution B consisted of 1 N HCl, 4% TCA and 5% FeCl 3 -6H 2 0. One hundred microliters of the test sample was incubated with 1 ml of solution A at 37°C for 10 min, and the reaction was terminated by the addition of 1 ml solution B. The absorbance at 525 nm was measured. One unit was defined as the formation of 1 µmol of hydroxamic acid per min. L-glutamic acid γ-monohydroxamate was used as the standard. To adapt the microtiter plate assay for mutant screening, microtiter plates were filled with 30 μl sample and 50 μl solution A per well, then incubated at 37°C for 20 min. The reaction was terminated by the addition of 50 μl of solution B. The absorbance at 525 nm was measured by a plate reader (SpectraMaxM2, Molecular Devices).
Plate assay C. glutamicum, carrying the random mutated MTG expression vector and SAM-P45 expression vector pVSS1 , was incubated on a CM2G plate, containing 25 mg/l Km and 5 mg/l Cm at 30°C for 24 h, then transferred onto a nitrocellulose membrane (ADVAN-TEC MFS, INC.). This membrane was incubated on the MMTG medium plate, containing 25 mg/l kanamaycin and 5 mg/l chloramphenicol at 30°C for 24 h. After incubation, this membrane was transferred onto the stainless steel plate. A 6-ml substrate solution, consisting of 0.12 M CBZ-GlnGly, 0.4 M NH 2 OH, 0.04 M glutathione (reduced form), and 0.2 M MES, pH6.0, were sprayed on the membrane, and this sprayed form was incubated at 37°C for 45 min. Reaction was stopped by the spraying on Solution B, which consisted of 1 N HCl, 4% TCA and 5% FeCl 3 -6H 2 O. Yellow around a colony was taken to be inactive MTG, while red was judged to be active MTG.
Cultivation of the recombinant bacteria expressing random mutants
After plate assay, the deepwell microtiter plate culture and test tube culture were carried out as described in "the cultivation of the rational mutants", except that Km (25 μg/ml) and Cm (5 μg/ml) were added to culture media.
Determination of protein concentration
Analytical reverse-phase HPLC was performed using a Vydac C4 column (214TP5410, 4.6-mm internal diameter × 10 cm, Grace Davison Discovery Science™). The column was equilibrated with 24% acetonitrile and 0.1% trifluoroacetic acid/water, and the proteins were eluted with a linear acetonitrile gradient from 24% to 40% in 0.1% trifluoroacetic acid/water over 20 min at a flow rate of 1 ml/min at ambient temperature. The eluent was monitored by UV absorbance at 280 nm. The concentration of MTG was determined by reverse-phase HPLC, using purified wildtype enzyme as a protein standard . Wild-type MTG was prepared from the culture supernatant of Streptoverticillium sp. S-8112 as described previously .
Purified wild-type enzyme concentration was measured by Bradford method, using Bio-Rad Protein Assay Kit. Bovine Serum Albumin (Nacarai Tesque, Inc., Kyoto, Japan) was used as the protein standard.
Purification of MTG
Activated MTG solution was diafiltrated 10-fold with 20 mM sodium acetate, pH5.5, and applied to a cationexchange column (RESOURCE S 6 ml; GE Healthcare UK Ltd.) equilibrated with 20 mM sodium acetate, pH5.5. After the column was washed with one column-volume of the same buffer, MTG was eluted with a linear gradient of sodium chloride from 0 to 500 mM over ten-column volumes at a flow rate of 6 ml/min. Fractions were assayed by the hydroxamate method and analytical reverse-phase HPLC. Fractions at the top, showing the same specific activity, were collected to remove derivatives.
For buffer-exchange, the collected fractions were applied to a gel filtration column (Sephadex G25 M, GE Healthcare UK Ltd.) equilibrated with 20 mM sodium phosphate, pH 6.0, and the proteins were eluted with the same buffer. Purified MTG fractions were frozen at −80°C before use.
Results
Design of the rational mutation of MTG Rational mutagenesis was first attempted. We calculated the percent solvent-accessibility surface area (SAS) of each amino-acid residue in the mature MTG region. The percent SAS was obtained by dividing the side chain SAS by the total SAS. SAS of each amino-acid residue in MTG was calculated by Discovery Studio (Accelrys Software Inc.). The original method was described by Eisenhaber et al. 1995 . The three-dimensional structure of MTG was determined (Kashiwagi et al. 2002) . We considered that amino acid residues, with high value of percent SAS, had a possibility to interact with substrates, and that the region within a 15Å space from the active center site as the hotspace for the mutation. Among 90 amino-acid residues within a 15Å space from the active center site Cys64, we selected 40 amino-acid residues with high value of percent SAS (Table 1) . We have called this novel methodology WASH-ROM. We determined one to six (mainly four or five) replacement amino-acid residues for each amino acid. In the model structure of the complex, numerous hydrophobic and aromatic residues interacted directly with the substrate (Tagami et al. 2009 ), implicating that the hydrophobic and/or π-π interactions are important for substrate recognition. Then, most of the residues were substituted to the hydrophobic and/or aromatic residues to increase the interactions (e.g. D3F, D3L, etc.), and the rest of the residues were replaced to the similar amino acids not to interfere the interactions (e.g. D3N, E58D....).
Preparation and screening rationally designed mutants
Rationally designed mutant expression vectors were constructed using the QuickChange® II Site-Directed Mutagenesis Kit (STRATAGENE®) (see "Materials and methods"). pPSPTG11 ) was used for the template DNA. pPSPTG1 expresses wild-type pro-MTG, however, Nterminal amino-acid sequence of MTG was differed from that of wild-type MTG after proteolytical activation . pPSPTG11 expresses altered Pro-MTG, whose Cterminal of pro-peptide was changed from Arg-Ala-Pro to Gly-Pro-Lys. N-terminal amino-acid sequence of MTG was equal to that of wild-type MTG after proteolytical activation . 151 mutant vectors were constructed in E. coli and transformed into C. glutamicum. The mutants constructed above were cultivated in a deepwell microtiter plate and proteolytically activated in another deepwell microtiter plate (see "Materials and methods"). Enzyme activity was measured in the microtiter plates as well as the total protein concentration. Of the initially screened mutants, 84 mutants showed a higher or equal specific activity as the wild-type MTG. These mutants were cultivated in one test tube and proteolytically activated in another test tube (see "Materials and methods"). Finally, the specific activities of the screened enzymes were precisely calculated by measuring their protein concentrations with RP-HPLC. Of the second group of screened mutants, 32 mutants showed a higher specific activity (Table 2) . Wild-type MTG exhibited 27.2 U/mg (standard deviation was 1.6. 26 U/mg was reported by Date et al. 2003) , and 8 mutants (D3F, R26F, W59F, V65I, Q74A, Y75F, Y75A, and T77S) with more than 1.3 times the specific activity of the wild-type enzyme. Among them, Y75F exhibited the highest Amino acid residues, which have the high percent SAS (solvent accessibility surface area) within a 15Å space of the active center Cys64, are shown. The percentage of SAS was obtained by dividing the side chain SAS by the total SAS. Amino acid residues are numbered from the mature N terminus of the wild-type protein activity (41.7 U/mg), corresponding to 1.5 times that of the wild-type enzyme.
Assignment of the beneficial positions of rational mutation on the three-dimensional (3D) structure
The MTG molecule forms a single, compact domain and adopts a disk-like shape with a deep cleft at the edge of the disk. Cys64, the residue essential for the catalytic activity, exists at the bottom of the cleft. The mutations responsible for the increased specific activity were assigned on the 3D structure. Figure 1 is schematic ribbon drawings of the MTG molecule viewed from above the front side (Kashiwagi et al. 2002) . First, V65, located next to the active center site comprises the internal residues of MTG (percent SAS of V65 is 3.0). Minor change (replacement Val with Ile) led to higher specific activity. Next, we found two regions related to increased activity, which were both localized in a symmetric relation to each other in the disk-like structure of MTG. One region, including Y75, Q74, T77, and R238, was located on the surface of the front side of the MTG. In particular, Y75 is located within 10Å of Cys64, and its side chain faces Cys64. The highest activity was gained by a replacement with Phe at this position. This region may be related to substrate recognition. The other region, including H289, E28, R26, S303, and S299, was located on the back side of the MTG, as reported in the literature (Kashiwagi et al. 2002) . Except for E28, replacement with hydrophobic amino acids led to increased specific activity. These residues may be also related to substrate recognition.
Construction of a novel plate assay for efficient screening of random beneficial mutants
To explore beneficial mutations by random mutagenesis, we have attempted to establish a novel plate assay to readily screen positive candidates with higher activity Rationally designed mutation points assigned on the threedimensional structure. Schematic ribbon drawings of the MTG molecule viewed from above the front side (Kashiwagi et al. 2002) . Amino-acid residues are numbered from the mature N terminus of the wild-type protein. Cys64 and the mutated amino-acid residues are indicated by the combination of one character notation and a number. Side chains are represented by a stick model. The illustration was drawn with the program Quanta (Accelrys) The specific activities of 32 mutants selected by rational mutagenesis are shown. All mutants have the mature N terminus of the wild-type protein.
The enzyme activity assay and protein concentration measurement were carried out as described in "Materials and methods" compared to the wild-type MTG. Previously, we demonstrated that active MTG can be efficiently secreted in C. glutamicum by using the wild-type pro-MTG expression plasmid pPSPTG1 and the activation protease SAM-P45 expression plasmid pVSS1 . Based on the findings, this liquid assay system was transferred to the plate assay system. Figure 2 shows the typical result. When C. glutamicum is grown on the membrane, the activated form of MTG can be detected by means of sprayed substrate solution. C. glutamicum ATTC13869, carrying pPSPTG1 and pVSS1, exhibited red (Fig. 2a) , while C. glutamicum ATTC13869, carrying pPK4 , and pVSS1 exhibited yellow color (Fig. 2b) . It was thus possible to efficiently distinguish the red active mutants from the inactive mutants, which were yellow color.
Screening for random mutation library Figure 3 summarizes the screening process. The mutant library was initially constructed using error-prone PCR, as described in the Materials and Methods. The mutation rate was controlled so as to be 2 or 3 base pairs in the MTGencoding region (Taguchi et al. 1998) . Approximately 24,000 mutants were obtained as a bacterial colony formation on the plate. All of the mutants were subjected to the plate assay. Approximately 5,000 mutants showed activity. At this step, mutants which had lost activity were efficiently eliminated using the plate assay. These positive mutants were sequentially subjected to the second and third screening. In the second screening, all of the 5,000 mutants were cultivated using the deepwell microtiter plate, followed by hydroxamate assay with the microtiter plate. In the third screening, the selected 200 mutants were cultivated using the test tube, followed by hydroxamate assay with the test tube, and finally the 78 mutants were obtained as positive candidates. DNA sequencing of the 78 mutants revealed that 32 mutants had single to triple mutations, while 46 mutants had no mutations. The 32 mutants included 5 overlapping mutants, which had the same mutation. After removing overlapping mutants, the specific activities of 27 mutants were precisely calculated by measuring their protein concentrations with RP-HPLC. In these 27 mutants, 11 mutants clearly showed higher specific activity than wild-type MTG. These mutants include 15 point mutations, including H289Y, which was also selected by rational mutation (Table 3) . They exhibit additional Nterminal tetrapeptide Phe-Arg-Ala-Pro (FRAP).
Analysis of selected mutants
To evaluate the effect of single mutations, we constructed 14 mutants, except H289Y, using the QuickChange® II SiteDirected Mutagenesis Kit (STRATAGENE®) (see Material & Methods) . pPSPTG11 ) was used as the template DNA for mutagenesis. pPSPTG11 expressed altered pro-MTG. N-terminal amino-acid sequence of MTG was equal to that of wild-type MTG after proteolytical activation . Purified wild-type MTG showed 27 U/mg. Ten of the 14 purified mutated proteins exhibited higher specific activities than the wild-type enzyme (Table 4) . M16T exhibited the highest (42.5 U/ mg), 1.6 times higher specific activity than the wild-type enzyme. S199A exhibited 30.0 U/mg, however N18 mutant, having the same mutation point, exhibited 42.9 U/mg (Table 3) . We confirmed that N18 mutant had N-terminal four amino-acid residues extension (FRAP-extension). Purified FRAP-S199A was determined to be 45.0 U/mg. This value was the highest among all of the mutants. The specific activities of FRAP-MTG and MTG were approximately the same (data not shown). Both mutations (S199A) and FRAPextension evidently cooperated with each other in the higher specific activity of MTG.
Assignment of beneficial positions at random mutation on the 3D structure
The mutations responsible for the increased specific activity, which were assigned to the 3D structure and the A B Fig. 2 Typical result of plate assay for detection of activated transglutaminase. a C. glutamicum ATTC13869, carrying pPSPTG1 and pVSS1 , displaying the positive, red zone, which appeared around the colony. b C. glutamicum ATTC13869, carrying pPK4 and pVSS1 , displaying the negative, yellow zone, which appeared around the colony Fig. 3 The screening process of random mutagenesis. This is a flowchart showing the screening process of the random mutagenesis. The numbers in the square boxes indicate the numbers of mutants at each of the screening step two regions were identified. Figure 4 is schematic ribbon drawings of the MTG molecule viewed from above the rear side (Kashiwagi et al. 2002) . One region, including A10, P12, D14, M16, V30, and N32, was located at the outer surface of the protrusion that contains N terminus (on the left side surface of the MTG, as defined in the literature (Kashiwagi et al. 2002) ). Except for D14, replacement by hydrophilic amino acids led to increased specific activity. Marx et al. reported that all single point mutations related to changed thermal properties of MTG are located in the Nterminal domain (Marx et al. 2008) . Further, combination of FRAP-extension with the S199A mutation led to the highest specific activity. This region is an important region for further improvement in the future. The other region included Y34, Y42, and S199, which are internal residues of the MTG. The SAS percentages of Y34, Y42, and S199 are 2.0, 5.7 and 0.0, respectively. These replacements may be a good fit the surrounding amino-acid residues.
Discussion
To improve the activity of MTG, we have applied two different approaches. Rational mutagenesis, WASH-ROM, was adopted to survey the beneficial positions that can lead to the improvement of MTG activity. The region for mutation was targeted to the surrounding area of the active center Cys64, which is located at the hydrophobic core of MTG. Beneficial positions were addressed evenly on the two opposite sides. One region corresponds to the surface of the front of the MTG, while the other region is located on the back side of the MTG. These two regions may be related to substrate recognition. Further studies are required. In terms of the identification of beneficial positions, this distance-based approach would be applicable to survey regions further away from the active center site. It would be an efficient approach to obtain mutants with improved activity, because interactions between enzymes and substrates are relatively weak Specific activities of 11 mutants, selected by the screening process performed by random mutagenesis (Fig. 3) , are shown. Mutant numbers are derived from 200 mutants after first hydroxamate assay. All mutants have N-terminal four amino acid residues extension. The enzyme activity assay and protein concentration measurement were carried out as described in "Materials and methods" Randomly screened mutation points assigned on the threedimensional structure. Schematic ribbon drawings of the MTG molecule viewed from above the rear side (Kashiwagi et al. 2002) . Amino-acid residues are numbered from the mature N terminus of the wild-type protein. Cys64 and the mutated amino-acid residues are indicated by the combination of one character notation and a number. The side chains are represented by a stick model. The illustration was drawn with the program Quanta (Accelrys) enough in comparison with those of protein-protein or protein-peptide, and they have potential to improve by modifying their binding surface due to amino-acid substitutions in enzymes. To confirm the efficacy of this approach, it is necessary to investigate whether it is possible to apply for another enzyme. On the other hand, random mutagenesis was expected to be effective in surveying entire region of MTG. The novel plate assay facilitated the screening process. In fact, beneficial mutations which differed from those identified by a rational approach were obtained by a random approach. It should be noted that the N-terminal domain, which is far from active center Cys 64, was important. In particular, a synergistic activity increase was obtained by a combination of the N-terminal four residues extension, FRAP, with the S199A mutation. The N-terminal domain is reported to also have a potential for acquiring thermal stability (Marx et al. 2008) . Taken together with these findings, the N-terminal region is an attractive target for mutagenesis performed to gain activity-increased and/or stability-increased mutants by multiply combining beneficial mutations, as shown by the mutants obtained here. In this study, primarily surveying beneficial positions related to activity-increase has been efficiently performed by the two different approaches, but fine-tuned amino-acid substitutions at individual positions could not be explored at the present. Therefore, the next generation enzyme evolution is underway to gain further attractive evolved enzymes with highly improved activity by saturation mutagenesis and mutation scrambling (Taguchi and Tsuge 2008) .
